nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—IL1B—Graves' disease	0.787	1	CbGaD
Minocycline—CASP1—connective tissue—Graves' disease	0.00438	0.0609	CbGeAlD
Minocycline—CYCS—eye—Graves' disease	0.00438	0.0609	CbGeAlD
Minocycline—CYCS—connective tissue—Graves' disease	0.00422	0.0586	CbGeAlD
Minocycline—CASP3—eye—Graves' disease	0.00375	0.0521	CbGeAlD
Minocycline—CASP3—connective tissue—Graves' disease	0.00361	0.0502	CbGeAlD
Minocycline—CASP1—pituitary gland—Graves' disease	0.00338	0.0469	CbGeAlD
Minocycline—CASP1—adipose tissue—Graves' disease	0.00336	0.0467	CbGeAlD
Minocycline—IL1B—eye—Graves' disease	0.003	0.0416	CbGeAlD
Minocycline—CASP1—thyroid gland—Graves' disease	0.00291	0.0405	CbGeAlD
Minocycline—IL1B—connective tissue—Graves' disease	0.00289	0.0401	CbGeAlD
Minocycline—CYCS—thyroid gland—Graves' disease	0.0028	0.0389	CbGeAlD
Minocycline—CASP3—pituitary gland—Graves' disease	0.00278	0.0387	CbGeAlD
Minocycline—CASP3—adipose tissue—Graves' disease	0.00277	0.0385	CbGeAlD
Minocycline—MMP9—eye—Graves' disease	0.0025	0.0347	CbGeAlD
Minocycline—MMP9—connective tissue—Graves' disease	0.00241	0.0334	CbGeAlD
Minocycline—CASP3—thyroid gland—Graves' disease	0.0024	0.0334	CbGeAlD
Minocycline—IL1B—pituitary gland—Graves' disease	0.00222	0.0309	CbGeAlD
Minocycline—IL1B—adipose tissue—Graves' disease	0.00221	0.0308	CbGeAlD
Minocycline—VEGFA—pituitary gland—Graves' disease	0.00219	0.0304	CbGeAlD
Minocycline—VEGFA—adipose tissue—Graves' disease	0.00218	0.0303	CbGeAlD
Minocycline—IL1B—thyroid gland—Graves' disease	0.00192	0.0266	CbGeAlD
Minocycline—ALOX5—connective tissue—Graves' disease	0.0019	0.0264	CbGeAlD
Minocycline—VEGFA—thyroid gland—Graves' disease	0.00189	0.0262	CbGeAlD
Minocycline—MMP9—adipose tissue—Graves' disease	0.00185	0.0257	CbGeAlD
Minocycline—ALOX5—adipose tissue—Graves' disease	0.00146	0.0203	CbGeAlD
Minocycline—SLC22A8—eye—Graves' disease	0.00134	0.0186	CbGeAlD
Minocycline—ALOX5—thyroid gland—Graves' disease	0.00126	0.0176	CbGeAlD
Minocycline—CASP1—IFN-gamma pathway—IL1B—Graves' disease	0.000743	0.00526	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—CD4—Graves' disease	0.00073	0.00516	CbGpPWpGaD
Minocycline—CYCS—miRNA Regulation of DNA Damage Response—FAS—Graves' disease	0.000728	0.00515	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—HLA-E—Graves' disease	0.000727	0.00514	CbGpPWpGaD
Minocycline—CASP3—Caspase Cascade in Apoptosis—FASLG—Graves' disease	0.000726	0.00513	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—FASLG—Graves' disease	0.000723	0.00511	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—CD40—Graves' disease	0.000711	0.00502	CbGpPWpGaD
Minocycline—CASP3—Caspase Cascade in Apoptosis—FAS—Graves' disease	0.0007	0.00495	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—CTLA4—Graves' disease	0.0007	0.00495	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—FAS—Graves' disease	0.000698	0.00493	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—CD8A—Graves' disease	0.000671	0.00474	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—FAS—Graves' disease	0.000668	0.00472	CbGpPWpGaD
Minocycline—MMP9—amb2 Integrin signaling—ICAM1—Graves' disease	0.000665	0.0047	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—FASLG—Graves' disease	0.00066	0.00466	CbGpPWpGaD
Minocycline—VEGFA—Hypertrophy Model—IFNG—Graves' disease	0.00064	0.00452	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—HLA-DQB1—Graves' disease	0.000637	0.0045	CbGpPWpGaD
Minocycline—MMP9—IL1 and megakaryotyces in obesity—IFNG—Graves' disease	0.000637	0.0045	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—FAS—Graves' disease	0.000636	0.0045	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—FASLG—Graves' disease	0.000631	0.00446	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—FASLG—Graves' disease	0.000619	0.00438	CbGpPWpGaD
Minocycline—CASP3—DNA Damage Response—FAS—Graves' disease	0.000608	0.0043	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—IL2RA—Graves' disease	0.000605	0.00428	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—IL2RA—Graves' disease	0.000605	0.00427	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—HLA-A—Graves' disease	0.000598	0.00423	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000597	0.00422	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—FAS—Graves' disease	0.000597	0.00422	CbGpPWpGaD
Minocycline—CASP1—Amyotrophic lateral sclerosis (ALS)—TNF—Graves' disease	0.000596	0.00421	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—IFNG—Graves' disease	0.000587	0.00415	CbGpPWpGaD
Minocycline—IL1B—Type II interferon signaling (IFNG)—IFNG—Graves' disease	0.000587	0.00415	CbGpPWpGaD
Minocycline—CASP3—miRNA Regulation of DNA Damage Response—FAS—Graves' disease	0.000587	0.00415	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.000579	0.00409	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—HLA-DQB1—Graves' disease	0.000577	0.00408	CbGpPWpGaD
Minocycline—IL1B—Cellular roles of Anthrax toxin—TNF—Graves' disease	0.000576	0.00407	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—HLA-B—Graves' disease	0.000572	0.00405	CbGpPWpGaD
Minocycline—CYCS—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—Graves' disease	0.000571	0.00403	CbGpPWpGaD
Minocycline—MMP9—IL1 and megakaryotyces in obesity—IL1B—Graves' disease	0.000568	0.00402	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—CD4—Graves' disease	0.000567	0.00401	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—FASLG—Graves' disease	0.000559	0.00395	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—HLA-DRB1—Graves' disease	0.000546	0.00386	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—FAS—Graves' disease	0.000539	0.00381	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—FAS—Graves' disease	0.000539	0.00381	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL2RA—Graves' disease	0.000536	0.00379	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—FASLG—Graves' disease	0.000533	0.00376	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—HLA-A—Graves' disease	0.00053	0.00375	CbGpPWpGaD
Minocycline—IL1B—IFN-gamma pathway—IFNG—Graves' disease	0.000521	0.00368	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—HLA-B—Graves' disease	0.000518	0.00366	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.000518	0.00366	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—FAS—Graves' disease	0.000514	0.00363	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.00051	0.00361	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—CXCL10—Graves' disease	0.000509	0.0036	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—FASLG—Graves' disease	0.000506	0.00358	CbGpPWpGaD
Minocycline—IL1B—IL27-mediated signaling events—TNF—Graves' disease	0.000504	0.00356	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—FASLG—Graves' disease	0.0005	0.00353	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—FAS—Graves' disease	0.000494	0.00349	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000494	0.00349	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—TNF—Graves' disease	0.000489	0.00346	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—FAS—Graves' disease	0.000488	0.00345	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—FAS—Graves' disease	0.000488	0.00345	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—ICAM1—Graves' disease	0.000486	0.00343	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IL2RA—Graves' disease	0.000485	0.00343	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—CD8A—Graves' disease	0.000485	0.00343	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—HLA-DRB1—Graves' disease	0.000484	0.00342	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-E—Graves' disease	0.000484	0.00342	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—FAS—Graves' disease	0.000482	0.0034	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—HLA-A—Graves' disease	0.00048	0.00339	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CD40—Graves' disease	0.000473	0.00334	CbGpPWpGaD
Minocycline—CYCS—FAS pathway and Stress induction of HSP regulation—TNF—Graves' disease	0.00047	0.00333	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CTLA4—Graves' disease	0.000466	0.0033	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—CXCL10—Graves' disease	0.000461	0.00326	CbGpPWpGaD
Minocycline—CASP3—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—Graves' disease	0.00046	0.00325	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000454	0.00321	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.000452	0.0032	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—FASLG—Graves' disease	0.000443	0.00313	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—FAS—Graves' disease	0.00044	0.00311	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—HLA-DRB1—Graves' disease	0.000438	0.0031	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—FAS—Graves' disease	0.000427	0.00302	CbGpPWpGaD
Minocycline—IL1B—Monoamine Transport—TNF—Graves' disease	0.000427	0.00302	CbGpPWpGaD
Minocycline—CYCS—Ceramide signaling pathway—TNF—Graves' disease	0.000423	0.00299	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-E—Graves' disease	0.000423	0.00299	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IL2RA—Graves' disease	0.000414	0.00292	CbGpPWpGaD
Minocycline—CASP3—Amyotrophic lateral sclerosis (ALS)—TNF—Graves' disease	0.000411	0.00291	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—HLA-A—Graves' disease	0.000405	0.00287	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—FASLG—Graves' disease	0.000404	0.00286	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.000404	0.00286	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—IFNG—Graves' disease	0.000399	0.00282	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—IL1B—Graves' disease	0.000391	0.00276	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00039	0.00276	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—FAS—Graves' disease	0.00039	0.00276	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000386	0.00273	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—CD4—Graves' disease	0.000385	0.00272	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-DQB1—Graves' disease	0.000384	0.00271	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—TNF—Graves' disease	0.00038	0.00269	CbGpPWpGaD
Minocycline—CASP3—TWEAK Signaling Pathway—TNF—Graves' disease	0.00038	0.00268	CbGpPWpGaD
Minocycline—CASP3—FAS pathway and Stress induction of HSP regulation—TNF—Graves' disease	0.00038	0.00268	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL2RA—Graves' disease	0.000378	0.00267	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—IFNG—Graves' disease	0.00037	0.00261	CbGpPWpGaD
Minocycline—CYCS—Caspase Cascade in Apoptosis—TNF—Graves' disease	0.000368	0.0026	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—IL1B—Graves' disease	0.000356	0.00252	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IFNG—Graves' disease	0.000354	0.0025	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CXCL10—Graves' disease	0.000353	0.0025	CbGpPWpGaD
Minocycline—MMP9—Matrix Metalloproteinases—TNF—Graves' disease	0.000345	0.00244	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-B—Graves' disease	0.000345	0.00244	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—ICAM1—Graves' disease	0.000337	0.00238	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—FASLG—Graves' disease	0.000337	0.00238	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.000335	0.00237	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.00033	0.00233	CbGpPWpGaD
Minocycline—MMP9—amb2 Integrin signaling—TNF—Graves' disease	0.000328	0.00232	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—FASLG—Graves' disease	0.000326	0.00231	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000326	0.0023	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—FAS—Graves' disease	0.000325	0.0023	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL2RA—Graves' disease	0.000323	0.00228	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IFNG—Graves' disease	0.00032	0.00226	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—HLA-DRB1—Graves' disease	0.00032	0.00226	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-A—Graves' disease	0.00032	0.00226	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000319	0.00226	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—TNF—Graves' disease	0.000316	0.00223	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—IL1B—Graves' disease	0.000316	0.00223	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL1B—Graves' disease	0.000316	0.00223	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—FAS—Graves' disease	0.000315	0.00222	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—FASLG—Graves' disease	0.000306	0.00216	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—ICAM1—Graves' disease	0.000305	0.00216	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IFIH1—Graves' disease	0.000301	0.00213	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.000301	0.00213	CbGpPWpGaD
Minocycline—CASP3—Caspase Cascade in Apoptosis—TNF—Graves' disease	0.000297	0.0021	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—FAS—Graves' disease	0.000295	0.00208	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—TNF—Graves' disease	0.000294	0.00208	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—IFNG—Graves' disease	0.000294	0.00208	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-DRB1—Graves' disease	0.000292	0.00206	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—TNF—Graves' disease	0.000284	0.00201	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.000282	0.00199	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.000279	0.00197	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—CD4—Graves' disease	0.000279	0.00197	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—FASLG—Graves' disease	0.000277	0.00196	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000276	0.00195	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IFNG—Graves' disease	0.000273	0.00193	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000272	0.00192	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IFNG—Graves' disease	0.000271	0.00191	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—Graves' disease	0.00027	0.00191	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—FAS—Graves' disease	0.000267	0.00189	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000266	0.00188	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-E—Graves' disease	0.000264	0.00187	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—TNF—Graves' disease	0.000264	0.00186	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IFNG—Graves' disease	0.000257	0.00181	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—IFNG—Graves' disease	0.000255	0.0018	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000255	0.0018	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—IL1B—Graves' disease	0.00025	0.00177	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IFNG—Graves' disease	0.000248	0.00175	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000245	0.00173	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TNF—Graves' disease	0.000239	0.00169	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—HLA-E—Graves' disease	0.000237	0.00168	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—ICAM1—Graves' disease	0.000234	0.00166	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IFNG—Graves' disease	0.000232	0.00164	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TNF—Graves' disease	0.000229	0.00162	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—TNF—Graves' disease	0.000229	0.00162	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL1B—Graves' disease	0.000229	0.00162	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—CD4—Graves' disease	0.000226	0.0016	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IL1B—Graves' disease	0.000221	0.00156	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—Graves' disease	0.000218	0.00154	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IFNG—Graves' disease	0.000213	0.00151	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000213	0.0015	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.00021	0.00148	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—TNF—Graves' disease	0.000207	0.00147	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TNF—Graves' disease	0.000207	0.00147	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—TNF—Graves' disease	0.000203	0.00143	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000202	0.00143	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GC—Graves' disease	0.000197	0.00139	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL1B—Graves' disease	0.00019	0.00134	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—TNF—Graves' disease	0.00019	0.00134	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.000188	0.00133	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000186	0.00132	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000184	0.0013	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000183	0.00129	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TNF—Graves' disease	0.000181	0.00128	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IFNG—Graves' disease	0.000178	0.00126	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—ICAM1—Graves' disease	0.000177	0.00125	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.000176	0.00125	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFIH1—Graves' disease	0.000175	0.00124	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.000174	0.00123	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—IL1B—Graves' disease	0.000173	0.00122	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000169	0.00119	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—HLA-B—Graves' disease	0.000169	0.00119	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000166	0.00118	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TNF—Graves' disease	0.000166	0.00117	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.000166	0.00117	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—Graves' disease	0.000166	0.00117	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—TNF—Graves' disease	0.00016	0.00113	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.00016	0.00113	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000159	0.00113	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL1B—Graves' disease	0.000159	0.00112	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000154	0.00109	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000153	0.00108	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TNF—Graves' disease	0.00015	0.00106	CbGpPWpGaD
Minocycline—CYCS—Metabolism—B3GNT2—Graves' disease	0.000149	0.00105	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000142	0.001	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-E—Graves' disease	0.000138	0.000976	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TNF—Graves' disease	0.000138	0.000975	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD40—Graves' disease	0.000135	0.000954	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—Graves' disease	0.000134	0.000944	CbGpPWpGaD
Minocycline—CASP1—Immune System—CTLA4—Graves' disease	0.000133	0.00094	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000133	0.000939	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000132	0.000932	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000129	0.000911	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TNF—Graves' disease	0.000125	0.000885	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—ICAM1—Graves' disease	0.000123	0.000869	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GC—Graves' disease	0.000121	0.000857	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—Graves' disease	0.00012	0.00085	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000116	0.000823	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—Graves' disease	0.000115	0.000815	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—Graves' disease	0.000113	0.000801	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000113	0.000799	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.00011	0.00078	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFIH1—Graves' disease	0.00011	0.000775	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DQB1—Graves' disease	0.00011	0.000774	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD8A—Graves' disease	0.000102	0.000723	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD4—Graves' disease	0.000101	0.000713	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-B—Graves' disease	9.84e-05	0.000695	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2RA—Graves' disease	9.22e-05	0.000652	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—B3GNT2—Graves' disease	9.18e-05	0.000649	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-A—Graves' disease	9.11e-05	0.000644	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-E—Graves' disease	8.63e-05	0.00061	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD40—Graves' disease	8.43e-05	0.000596	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TSHR—Graves' disease	8.33e-05	0.000589	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DRB1—Graves' disease	8.33e-05	0.000589	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTLA4—Graves' disease	8.31e-05	0.000587	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—Graves' disease	8.01e-05	0.000566	CbGpPWpGaD
Minocycline—CASP1—Immune System—ICAM1—Graves' disease	7.99e-05	0.000565	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2RA—Graves' disease	7.31e-05	0.000517	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DQB1—Graves' disease	6.84e-05	0.000484	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	6.81e-05	0.000481	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD8A—Graves' disease	6.39e-05	0.000452	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-B—Graves' disease	6.15e-05	0.000435	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNG—Graves' disease	6.08e-05	0.00043	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD4—Graves' disease	5.87e-05	0.000415	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TSHR—Graves' disease	5.78e-05	0.000409	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2RA—Graves' disease	5.76e-05	0.000407	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-A—Graves' disease	5.7e-05	0.000403	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1B—Graves' disease	5.42e-05	0.000383	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL10—Graves' disease	5.38e-05	0.000381	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DRB1—Graves' disease	5.2e-05	0.000368	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TSHR—Graves' disease	5.02e-05	0.000355	CbGpPWpGaD
Minocycline—IL1B—Immune System—ICAM1—Graves' disease	4.99e-05	0.000353	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2RA—Graves' disease	4.12e-05	0.000291	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNG—Graves' disease	3.8e-05	0.000269	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL10—Graves' disease	3.74e-05	0.000264	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD4—Graves' disease	3.67e-05	0.000259	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—Graves' disease	3.67e-05	0.000259	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL10—Graves' disease	3.24e-05	0.000229	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—Graves' disease	3.18e-05	0.000225	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2RA—Graves' disease	2.86e-05	0.000202	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2RA—Graves' disease	2.48e-05	0.000175	CbGpPWpGaD
